Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series

Optimization of our previously described pyrrolopiperidone series led to the identification of a new benzamide sub-series, which exhibits consistently high potency in biochemical and cell-based assays throughout the series. Strong inhibition of LPS-induced production of the cytokine TNFα is coupled...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2012-01, Vol.22 (1), p.613-618
Hauptverfasser: Oubrie, Arthur, Kaptein, Allard, de Zwart, Edwin, Hoogenboom, Niels, Goorden, Rianne, van de Kar, Bas, van Hoek, Maaike, de Kimpe, Vera, van der Heijden, Ruud, Borsboom, Judith, Kazemier, Bert, de Roos, Jeroen, Scheffers, Michiel, Lommerse, Jos, Schultz-Fademrecht, Carsten, Barf, Tjeerd
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Optimization of our previously described pyrrolopiperidone series led to the identification of a new benzamide sub-series, which exhibits consistently high potency in biochemical and cell-based assays throughout the series. Strong inhibition of LPS-induced production of the cytokine TNFα is coupled to the regulation of HSP27 phosphorylation, indicating that the observed cellular effects result from the inhibition of MK2. X-ray crystallographic and computational analyses provide a rationale for the high potency of the series.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2011.10.071